This paper studies how to integrate historical control data with experimental data to enhance A/B testing, while addressing the distributional shift between historical and experimental datasets. We propose a pessimistic data integration method that combines two causal effect estimators constructed based on experimental and historical datasets. Our main idea is to conceptualize the weight function for this combination as a policy so that existing pessimistic policy learning algorithms are applicable to learn the optimal weight that minimizes the resulting weighted estimator's mean squared error. Additionally, we conduct comprehensive theoretical and empirical analyses to compare our method against various baseline estimators across five scenarios. Both our theoretical and numerical findings demonstrate that the proposed estimator achieves near-optimal performance across all scenarios.

Yet, modern machine learning pipelines offer a promising solution--provided their predictions yield correct conclusions. We focus on Prediction-Powered Causal Inferences (PPCI), i.e., estimating the treatment effect in an unlabeled target experiment, relying on training data with the same outcome annotated but potentially different treatment or effect modifiers.

We study the estimation of distributional treatment effects in randomized experiments with imperfect compliance. When participants do not adhere to their assigned treatments, we leverage treatment assignment as an instrumental variable to identify the local distributional treatment effect--the difference in outcome distributions between treatment and control groups for the subpopulation of compliers. We propose a regression-adjusted estimator based on a distribution regression framework with Neyman-orthogonal moment conditions, enabling robustness and flexibility with high-dimensional covariates. Our approach accommodates continuous, discrete, and mixed discrete-continuous outcomes, and applies under a broad class of covariate-adaptive randomization schemes, including stratified block designs and simple random sampling. We derive the estimator's asymptotic distribution and show that it achieves the semiparametric efficiency bound. Simulation results demonstrate favorable finite-sample performance, and we demonstrate the method's practical relevance in an application to the Oregon Health Insurance Experiment.

Large Language Model (LLM)-based multi-agent systems show promise for automating real-world tasks but struggle to transfer across domains due to their domain-specific nature. Current approaches face two critical shortcomings: they require complete architectural redesign and full retraining of all components when applied to new domains. We introduce WORKFORCE, a hierarchical multi-agent framework that decouples strategic planning from specialized execution through a modular architecture comprising: (i) a domain-agnostic Planner for task decomposition, (ii) a Coordinator for subtask management, and (iii) specialized Workers with domain-specific tool-calling capabilities.

Despite recent progress in identifying latent causal structures using causal representation learning (CRL), what makes learned representations useful for causal downstream tasks and how to evaluate them are still not well understood. In this paper, we reinterpret CRL using a measurement model framework, where the learned representations are viewed as proxy measurements of the latent causal variables. Our approach clarifies the conditions under which learned representations support downstream causal reasoning and provides a principled basis for quantitatively assessing the quality of representations using a new Test-based Measurement EXclusivity (T-MEX) score. We validate T-MEX across diverse causal inference scenarios, including numerical simulations and real-world ecological video analysis, demonstrating that the proposed framework and corresponding score effectively assess the identification of learned representations and their usefulness for causal downstream tasks.

We study the problem of estimating the average treatment effect (ATE) in adaptive experiments where treatment can only be encouraged--rather than directly assigned--via a binary instrumental variable. Building on semiparametric efficiency theory, we derive the efficiency bound for ATE estimation under arbitrary, history-dependent instrument-assignment policies, and show it is minimized by a variance-aware allocation rule that balances outcome noise and compliance variability. Leveraging this insight, we introduce AMRIV--an Adaptive, Multiply-Robust estimator for Instrumental-Variable settings with variance-optimal assignment. AMRIV pairs (i) an online policy that adaptively approximates the optimal allocation with (ii) a sequential, influence-function-based estimator that attains the semiparametric efficiency bound while retaining multiply-robust consistency. We establish asymptotic normality, explicit convergence rates, and anytime-valid asymptotic confidence sequences that enable sequential inference. Finally, we demonstrate the practical effectiveness of our approach through empirical studies, showing that adaptive instrument assignment, when combined with the AMRIV estimator, yields improved efficiency and robustness compared to existing baselines.

There has been increasing research interest in AI/ML for social impact, and correspondingly more publication venues have refined review criteria for practice-driven AI/ML research. However, these review guidelines tend to most concretely recognize projects that simultaneously achieve deployment and novel ML methodological innovation. We argue that this introduces incentives for researchers that undermine the sustainability of a broader research ecosystem of social impact, which benefits from projects that make contributions on single front (applied or methodological) that may better meet project partner needs. Our position is that researchers and reviewers in machine learning for social impact must simultaneously adopt: 1) a more expansive conception of social impacts beyond deployment and 2) more rigorous evaluations of the impact of deployed systems.

Online Internet platforms require sophisticated marketing strategies to optimize user retention and platform revenue -- a classical resource allocation problem. Traditional solutions adopt a two-stage pipeline: machine learning (ML) for predicting individual treatment effects to marketing actions, followed by operations research (OR) optimization for decision-making. This paradigm presents two fundamental technical challenges. First, the prediction-decision misalignment: Conventional ML methods focus solely on prediction accuracy without considering downstream optimization objectives, leading to improved predictive metrics that fail to translate to better decisions. Second, the bias-variance dilemma: Observational data suffers from multiple biases (e.g., selection bias, position bias), while experimental data (e.g., randomized controlled trials), though unbiased, is typically scarce and costly --- resulting in high-variance estimates.

In randomized trials involving multiple treatments, bivariate survival outcomes present significant analytical challenges for making decisions. This paper addresses the problem of deriving optimal individualized treatment rules to maximize the joint survival probability beyond fixed time points $(t_1, t_2)$ through deep neural networks, while accounting for right censoring. We propose a novel approach that models treatment rules via stochastic policies, coupling marginal accelerated failure time models via link function to capture bivariate dependence. To enhance robustness and effectiveness of decision making, we introduce an adaptive prediction-powered method that leverages auxiliary predictions from machine learning models.

Decision-makers frequently must choose a single action from a finite set of alternatives -- for example, physicians selecting a treatment, investors choosing a portfolio risk level, or judges determining sentences. To improve outcomes, policymakers often issue policy rules or guidelines to inform such choices. In this paper, I show how to generally derive policy rules from observational data in a multi-action framework under relatively weak assumptions about the underlying structure of the heterogeneous sampled population. Conditional average treatment effects (CATEs) are consistently estimated via a weighted K-means algorithm, assuming the outcome model is correctly specified within each homogeneous subgroup. Feasible policy rules are then implemented via a standard decision tree, allowing for both perfect and imperfect adherence to treatment. The methodology is applied to treatment options for Hepatitis C (HCV) among patients co-infected with human immunodeficiency virus (HIV), a setting in which no uniform guideline exists for modern pharmaceutical therapies. The results identify a subgroup of patients with approximately an 80% probability of spontaneous HCV clearance without treatment. Estimation results also show that reallocating treatments among treated individuals could have reduced total treatment costs by CAN$3.6-4.9 million while still increasing aggregate health benefits relative to the status quo. These findings demonstrate that the proposed approach can generate improved, data-driven treatment guidelines for the management of HIV/HCV co-infected patients.